Last Updated : June 30, 2015
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on "Submit." For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Note that typically only patient groups may submit input; however, there is currently a pilot process for receiving patient input submissions from individual patients and caregivers (runs until August 3, 2015); see CADTH Update for Patient Groups – January 2015 for details.
Breo Ellipta
| Brand name | Generic name | Manufacturer | Indication(s) |
| Breo Ellipta | Fluticasone Furoate and Vilanterol (as trifenatate) | GlaxoSmithKline Inc. | Asthma |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| TBC | 2015-06-30 | 2015-08-20 | Submit |
Last Updated : June 30, 2015